Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malick Bio Idrissou

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Applied Radiation Oncology|June 22, 2026
Combination of External Beam Radiation Therapy and Immune Checkpoint Inhibitors in Cancer Treatment: Mechanisms, Limitations, and Clinical ApplicationsAnusha Muralidhar, Malick Bio Idrissou, Quaovi H Sodji
Applied Radiation Oncology|June 29, 2026
Clinical Evidence of Combining Radiopharmaceutical Therapy With Immune Checkpoint InhibitorsMalick Bio Idrissou, Anusha Muralidhar, Reinier Hernandez, et al.
Journal of the American Chemical Society|February 11, 2026
Development of Prostate-Specific Lysosome-Targeting DegradersDeqin Cai, Xuankun Chen, Yaxian Zhou, et al.
Pharmaceutics|July 2, 2021
Targeted Radionuclide Therapy Using Auger Electron Emitters: The Quest for the Right Vector and the Right RadionuclideMalick Bio Idrissou, Alexandre Pichard, Bryan Tee, et al.
Arxiv|September 26, 2025
Quantitative In Vivo Cherenkov Luminescence Imaging and Dosimetry of <sup>86</sup>Y-NM600Campbell D Haasch, Malick Bio Idrissou, Sydney Jupitz, et al.
EJNMMI Physics|February 6, 2026
Quantitative in vivo Cherenkov luminescence imaging and dosimetry of <sup>86</sup>Y-NM600Campbell D Haasch, Malick Bio Idrissou, Sydney Jupitz, et al.
Frontiers in Nuclear Medicine|October 2, 2024
Immunological effects of radiopharmaceutical therapyAmanda G Shea, Malick Bio Idrissou, Ana Isabel Torres, et al.
Journal for Immunotherapy of Cancer|April 25, 2024
Myeloid-derived suppressor cells attenuate the antitumor efficacy of radiopharmaceutical therapy using <sup>90</sup>Y-NM600 in combination with androgen deprivation therapy in murine prostate tumorsAnusha Muralidhar, Reinier Hernandez, Zachary S Morris, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Characterization and Calibration of the iQID Digital Autoradiography System for Direct Quantitative Imaging of Beta-Emitters in Tissue SamplesOhyun Kwon, Sean P Jollota, Adedamola O Adeniyi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 26, 2026
Preclinical Evaluation of [<sup>177</sup>Lu]Lu-ART-101 for Radiopharmaceutical Therapy of Advanced Prostate CancerMalick Bio Idrissou, Carolina Aguiar Ferreira, Hansel Comas Rojas, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Applied Radiation Oncology|June 22, 2026
Combination of External Beam Radiation Therapy and Immune Checkpoint Inhibitors in Cancer Treatment: Mechanisms, Limitations, and Clinical ApplicationsAnusha Muralidhar, Malick Bio Idrissou, Quaovi H Sodji
Applied Radiation Oncology|June 29, 2026
Clinical Evidence of Combining Radiopharmaceutical Therapy With Immune Checkpoint InhibitorsMalick Bio Idrissou, Anusha Muralidhar, Reinier Hernandez, et al.
Journal of the American Chemical Society|February 11, 2026
Development of Prostate-Specific Lysosome-Targeting DegradersDeqin Cai, Xuankun Chen, Yaxian Zhou, et al.
Pharmaceutics|July 2, 2021
Targeted Radionuclide Therapy Using Auger Electron Emitters: The Quest for the Right Vector and the Right RadionuclideMalick Bio Idrissou, Alexandre Pichard, Bryan Tee, et al.
Arxiv|September 26, 2025
Quantitative In Vivo Cherenkov Luminescence Imaging and Dosimetry of <sup>86</sup>Y-NM600Campbell D Haasch, Malick Bio Idrissou, Sydney Jupitz, et al.
EJNMMI Physics|February 6, 2026
Quantitative in vivo Cherenkov luminescence imaging and dosimetry of <sup>86</sup>Y-NM600Campbell D Haasch, Malick Bio Idrissou, Sydney Jupitz, et al.
Frontiers in Nuclear Medicine|October 2, 2024
Immunological effects of radiopharmaceutical therapyAmanda G Shea, Malick Bio Idrissou, Ana Isabel Torres, et al.
Journal for Immunotherapy of Cancer|April 25, 2024
Myeloid-derived suppressor cells attenuate the antitumor efficacy of radiopharmaceutical therapy using <sup>90</sup>Y-NM600 in combination with androgen deprivation therapy in murine prostate tumorsAnusha Muralidhar, Reinier Hernandez, Zachary S Morris, et al.
Biorxiv : the Preprint Server for Biology|February 9, 2026
Characterization and Calibration of the iQID Digital Autoradiography System for Direct Quantitative Imaging of Beta-Emitters in Tissue SamplesOhyun Kwon, Sean P Jollota, Adedamola O Adeniyi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 26, 2026
Preclinical Evaluation of [<sup>177</sup>Lu]Lu-ART-101 for Radiopharmaceutical Therapy of Advanced Prostate CancerMalick Bio Idrissou, Carolina Aguiar Ferreira, Hansel Comas Rojas, et al.
Pageof 2